The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis
Open accessAbstract
Background: Fascin-1 is an actin-bundling protein expressed in many human carcinomas, although absent from most normal epithelia. Fascin-1 promotes filopodia formation, migration and invasion in carcinoma cells; in mouse xenograft tumor models it contributes to metastasis. Fascin-1 is an interesting candidate biomarker for aggressive, metastatic carcinomas but data from individual studies of human tumors have not yet been pooled systematically. Methods: This systematic review was conducted in accordance with PRISMA guidelines, using fixed and random effects models, as appropriate, to undertake meta-analysis. Results: A total of 26 immunohistochemical studies of 5 prevalent human carcinomas were identified for meta-analysis. Fascin-1 was associated with increased risk of mortality for breast (pooled hazard ratio, (HR) = 2.58; 95% confidence interval (CI) 1.48 to 4.52;P= 0.001), colorectal (HR = 1.60 (1.37 to 1.86;P<0.001) and esophageal carcinomas (HR = 1.35; CI 1.13 to 1.60;P= 0.001). There was no evidence of association of fascin-1 with mortality in gastric and lung carcinomas. Fascin-1 was associated with increased risk of disease progression in breast (HR = 2.48; CI 1.38 to 4.46;P= 0.002) and colorectal carcinomas (HR = 2.12; CI 1.00 to 4.47;P= 0.05), but not with progression of lung carcinomas (HR = 0.95; CI 0.49 to 1.85;P= 0.9). Fascin-1 was associated with increased risk of lymph node metastasis in colorectal (pooled risk ratio (RR) = 1.47; CI 1.26 to 1.71;P<0.001) and gastric carcinomas (RR = 1.43; CI 1.21 to 1.70;P<0.001). There was no evidence of association of fascin-1 with lymph node metastasis in lung or esophageal carcinomas. Fascin-1 was associated with increased risk of distant metastasis in colorectal (RR = 1.70; CI 1.18 to 2.45;P= 0.004) and gastric carcinomas (RR = 1.93; CI 1.21 to 3.33;P= 0.02). No association with distant metastasis in esophageal carcinomas was observed. Pooling across all the carcinomas provided strong evidence for association of fascin-1 with increased risk of mortality (HR = 1.44; CI 1.24 to 1.68;P<0.001; n = 3,645), lymph node metastasis (RR = 1.36; CI 1.18 to 1.55;P<0.001; n = 2,906) and distant metastasis (1.76; 1.34 to 2.32;P<0.001; n = 1,514). Conclusions: Fascin-1 is associated consistently with increased risk of mortality in breast, colorectal and esophageal carcinomas and with metastasis in colorectal and gastric carcinomas. The results were stable to various sensitivity analyses and did not vary by predefined subgroups. These data will assist rational decision making for focusing investigations of fascin-1 as a biomarker or therapeutic target onto the most relevant carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979 · cited 1×
“Discussion The importance of demonstrating the reproducibility of biomarker studies to validate their utility for the clinic is increasingly well recognized [67].”
BackgroundGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 2×
“For breast carcinomas, it was reported that high fascin-1 mRNA levels were associated with a lung metastasis signature [16] and decreased overall and metastasis- free survival [13].”
BackgroundInvestigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
Cited by
Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia
Edafe, O., Antakia, R., Laskar, N., Uttley, L., & Balasubramanian, S. P. (2014) · British Journal of Surgery · doi:10.1002/bjs.9384 · Cited by 732
Tenascin C in metastasis: A view from the invasive front
Lowy, C. M., & Oskarsson, T. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1008331 · Cited by 178
Zhao, X., Gao, S., Ren, H., Sun, W., Zhang, H., Sun, J., Yang, S., & Hao, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3009 · Cited by 163
“Recent data from several groups have highlighted that fascin is upregulated in several human carcinomas, and fascin expression associates consistently with the most clinically aggressive tumors (29, 30).”
BackgroundAntakia, R., Edafe, O., Uttley, L., & Balasubramanian, S. P. (2015) · Thyroid · doi:10.1089/thy.2014.0101 · Cited by 92
Metadata
- Authors
- Tan, V. Y., Lewis, S. J., Adams, J. C., & Martin, R. M.
- Venue
- BMC Medicine
- Published
- 2013-02-26
- Volume
- 11
- Issue
- 1
- Pages
- 52-52
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W1984389940
- Cited by
- 179
- References
- 5
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/1741-7015-11-52
- The paper
- Tan, V. Y., Lewis, S. J., Adams, J. C., & Martin, R. M. (2013). Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. BMC Medicine. https://doi.org/10.1186/1741-7015-11-52
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.